NCT02351167View on ClinicalTrials.gov

Genetically Informed Smoking Cessation Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

822

Participants

Timeline

Start Date

May 20, 2015

Primary Completion Date

December 26, 2018

Study Completion Date

August 31, 2019

Conditions
Smoking Cessation
Interventions
DRUG

Combination NRT (Nicotine patch, Nicotine lozenge)

DRUG

Varenicline

DRUG

Placebo

BEHAVIORAL

Intensive smoking counseling

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Washington University School of Medicine

OTHER

NCT02351167 - Genetically Informed Smoking Cessation Trial | Biotech Hunter | Biotech Hunter